A new study has provided precise atomic data that shed light on the impact of charged ions from coronal mass ejections (CMEs) ...
Natixis Advisors LLC lowered its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 32.1% during ...
Ionis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive rights to market its wholly owned drug Tryngolza outside the United States ...
The Cool Down on MSN1d
Scientists make first-of-its-kind discovery that could impact drinking water for billions of people: 'Other groups overlooked the potential'"We were excited to develop a material that outperformed all existing materials." Scientists make first-of-its-kind discovery ...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty ...
A new study has provided precise atomic data that sheds light on the impact of charged ions from Coronal Mass Ejections (CMEs ...
The oceans hold an enormous amount of very diluted uranium that could potentially serve as a sustainable fuel source for ...
Highly charged heavy ions form a very suitable experimental field for investigating quantum electrodynamics (QED), the ...
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback